Kristin Abate - Chief Accounting Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Accounting Officer
Stock Symbol
KPTI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kristin Abate since 11/23/2023

Holdings reported by Kristin Abate for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 140K $128K $0.91 Nov 6, 2024 Direct

There are no transactions reported by Kristin Abate for Karyopharm Therapeutics Inc.